# Gallium-68 Citrate PET Used in Prostate Cancer

> **NCT02391025** · EARLY_PHASE1 · COMPLETED · sponsor: **Rahul Aggarwal** · enrollment: 39 (actual)

## Conditions studied

- Prostatic Neoplasms

## Interventions

- **DRUG:** Gallium-68 citrate
- **PROCEDURE:** Positron Emission Tomography (PET)

## Key facts

- **NCT ID:** NCT02391025
- **Lead sponsor:** Rahul Aggarwal
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-28
- **Primary completion:** 2023-06-15
- **Final completion:** 2023-06-15
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2023-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02391025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02391025, "Gallium-68 Citrate PET Used in Prostate Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02391025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*